baber/WOPTO huggingface dataset:
Patent NZ-543865-A (NZ)
Title: Lever handle return spring assembly
Inventor: ELLER DARREN C
IPC: E05B3/06
Filed: 2004-05-04
Abstract: A lever handle return spring assembly for a cylindrical lock mounted in a bored opening in a door includes support plates on opposite sides of the door. The support plates include cylindrically depressed inner regions that extend partially into the bored opening in the door to accommodate return springs and reduce the visual thickness of the return spring assembly. Spring housings containing compression springs turn within the support plate inner regions and are held in place by cover plates. The support plate, cover plate, spring housing and springs on each side of the door form complete assemblies that are attached to the door via through-bolts. At least one of the support plates preferably includes lock tabs that connect to the cylindrical lock to prevent rotation of the cylindrical lock relative to the door. The support plate and cover plate are designed for strength when stamped from a flat sheet.
Patent NZ-551237-A (NZ)
Title: Wrapped-cone fingers for skirt systems for air cushion vehicles
Inventor: DUBOSE KEITH W
IPC: B60V1/16
Filed: 2005-04-11
Abstract: A wrapped-cone finger 604 for an air-cushion vehicle skirt system 602 comprises an outer finger 606 with a leading edge and an opening 606b, and an inner cone 608 within the outer finger 606 with the leading edge of the cone forming an acute angle with the leading edge of the outer finger 606. The wrapped cone finger 606 can be operated to move from an inflated condition where the inner cone 608 will substantially block the opening 606b in the leading edge, to a deflated condition where the inner cone 608 will no longer substantially block the opening 606b in the leading edge. This design of wrapped-cone fingers 604 may be lightweight, inexpensive and resistant to snagging and scooping.
Patent NZ-552550-A (NZ)
Title: Insulin secretion by anthocyanins and anthocyanidins
Inventor: NAIR MURALEEDHARAN G
Filed: 2005-06-21
Abstract: Disclosed is a use of anthocyanin or anthocyanidin or mixture thereof in the manufacture of a medicament for increasing insulin secretion by pancreatic beta cells which secrete the insulin, in a patient in need thereof.
Patent NZ-554011-A (NZ)
Title: Antibody ("11C7") anti nogo A and its pharmaceutical use
Inventor: BARSKE CARMEN
Filed: 2003-12-09
Abstract: Disclosed are chimeric and humanised antibodies that are capable of binding to the human NogoA_623-640 polypeptide and that comprise specific sequential hypervariable regions. It is envisaged that such antibodies will aid neuronal regeneration following injury in the adult central nervous system. Further disclosed are said antibodies further comprising immunoglobulin heavy and light chains. Also described are polynucleotides encoding such antibodies; an expression vector comprising said polynucleotides; and a pharmaceutical composition comprising such antibodies.
Patent NZ-555176-A (NZ)
Title: Methods for administering DPD inhibitors in combination with 5-FU and 5-FU prodrugs
Inventor: SPECTOR TOM
IPC: A61K31/505
Filed: 2005-12-05
Abstract: The disclosure relates to the use of (i) a DPD inhibitor and (ii) 5-FU or a 5-FU prodrug for the preparation of a medicament for treating cancer in a patient, wherein the medicament is formulated for administration of the DPD inhibitor at least about 4 hours prior to administration of the 5-FU or the 5-FU prodrug, and further wherein the medicament is formulated to provide the 5-FU or 5-FU prodrug at a dose such that at its time of administration the 5-FU or 5-FU prodrug is present in the patient in at least 3-fold excess of the DPD inhibitor.
Patent NZ-556448-A (NZ)
Title: Substituted 5-phenyl pyrimidines I in therapy
Inventor: RHEINHEIMER JOACHIM
IPC: A61K31/505
Filed: 2006-01-30
Abstract: Disclosed is the use of substituted 5-phenyl pyrimidines of the formula I and their pharmaceutically acceptable salts for the manufacture of a medicament for therapy of cancer or cancerous diseases, wherein X is a group of the formula NR1R2; Y is a radical selected from the group consisting of halogen, cyano, alkyl, and alkoxy; and wherein the other substituents are as defined herein. Also disclosed is a pharmaceutical composition for therapy of cancer or cancerous diseases which comprises a 5-phenyl pyrimidine derivative as defined above or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.
Patent NZ-560439-A (NZ)
Title: Arrangement comprising a catheter and connector piece, and valve for passage of a catheter
Inventor: HARAND RALF
IPC: A61M16/04
Filed: 2006-03-28
Abstract: An arrangement of an instillation catheter and a connector 1 for attachment to a tracheal or endotracheal tube, the connector comprising a distal end 1a attached to the tube, a proximal end 1b attached to a respirator, a branch 5 for inserting the catheter, and a valve 2 with an opening made of elastically deformable material that can be opened by inserting the catheter and a distal nose section with a normally closed slit at its tip. The opening into which the catheter is inserted exerts pressure on the outer wall of the catheter and acts as a gas and water tight seal. The arrangement allows greater mobility to the catheter.
Patent NZ-561900-A (NZ)
Title: Crystalline hydrochloride salt of 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[(R)-2-hydroxy-3-(methanesulfonyl-methyl-amino)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide
Inventor: FATHEREE PAUL R
IPC: A61K31/46
Filed: 2006-04-05
Abstract: Disclosed is a crystalline salt form which is the hydrochloride salt of 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid {(1S,3R,5R)-8-[(R)-2-hydroxy-3-(methanesulfonyl-methyl-amino)propyl]-8-azabicyclo[3.2.1]oct-3-yl}amide or a solvate thereof. Also disclosed is the use of a crystalline salt form as defined above for manufacture of a medicament for the treatment of a medical condition in a mammal associated with 5-HT4 receptor activity (including disorders of reduced motility of the gastrointestinal tract, chronic constipation, constipation-predominant irritable bowel syndrome, diabetic and idiopathic gastroparesis, and functional dyspepsia).
Patent NZ-566358-A (NZ)
Title: Dairy product and process
Inventor: COKER CHRISTINA JUNE
IPC: A23C19/028
Filed: 2008-02-29
Abstract: Disclosed is a method for preparing a protein gel or a dairy protein gel ingredient, comprising: (a) providing a dairy starting material comprising casein; (b) adjusting the pH, if required, to a pre-selected point in the range 5.0-8.0; (c) subjecting the material with the pre-selected pH to a cooking step; (d) adjusting the pH of the cooked product to 3.8-7.5; (e) processing and/or packing the pH 3.8-7.5 product to form the final product or ingredient wherein at least 10% of the casein of the dairy starting material comprises alphas enriched casein having an alphas to beta casein weight ratio of greater than 1.25:1 or alphas depleted casein having an alphas to beta casein weight ratio of less than 0.8:1. Also disclosed is a method for preparing a cheese, a cheese-like product, or a dairy dessert comprising: (a) providing a dairy starting material comprising casein; (b) adjusting the pH, if required, to a pre-selected point in the range 5.0-8.0; (c) subjecting the material with the pre-selected pH to a cooking step; (d) adjusting the pH of the cooked product to 4.5-7.5 while liquid; (e) placing the pH 4.5-7.5 product into packaging while still liquid; and (f) providing conditions which allow the packaged product to set; wherein at least 10% of the casein comprises alphas enriched casein. Also disclosed is a method for making a dairy ingredient comprising: (a) providing a dairy starting material comprising casein and undenatured whey protein; (b) adjusting the pH, if required, to a pre-selected point in the range 5.0-8.0; (c) subjecting the material with the pre-selected pH to a cooking step; and (d) drying the heat treated material to form a powder; wherein at least 10% of the casein of the dairy starting material comprises alphas enriched casein having an alphas to beta casein weight ratio of greater than 1.25:1 or alphas depleted casein having an alphas to beta casein weight ratio of 5 less than 0.8:1.
Patent NZ-571250-A (NZ)
Title: A system for generating electric energy from renewable energy sources
Inventor: THORBURN KARIN
IPC: F03B13/18
Filed: 2006-03-29
Abstract: A system for generating electric energy from renewable energy sources is disclosed. The system includes a plurality of generator aggregates and a plurality of switchgear arranged in the sea. Each of the switchgear is connected to a plurality of the generator aggregates. The system further includes a plurality of primary intermediate stations and at least one secondary intermediate station, where each primary intermediate station is connected to a plurality of the switchgear. At least one secondary intermediate station is connected to a plurality of primary intermediate stations and to a land based electric network. The system includes switching means allowing selective connection of the at least one secondary intermediate station to various locations in the electric network.
Patent NZ-581206-A (NZ)
Title: A double walled plant container with a lid with at least one opening
Inventor: DONALD KATHERINE ELIZA
IPC: A01G9/02
Filed: 2010-11-02
Abstract: A plant container 1 comprises a base 2 and a wall 5 connected to the base to define a containment region 4, the wall 5 comprising a first wall panel 3 and a second wall panel 5 that is positioned adjacent to the first wall panel 3 to define a space 6 between them. The container 1 further comprises a lid 8 to at least partially cover the containment region 4. The lid 8 includes at least one opening 9 through which plants contained in the containment region 4 can extend.
Patent NZ-584021-A (NZ)
Title: Method of preparing water-soluble cellulose hydrolysis products using ionic liquids
Inventor: HOLBREY JOHN
IPC: C13K1/02
Filed: 2008-09-03
Abstract: A process for the preparation of water-soluble cellulose hydrolysis products is disclosed, which comprises admixing cellulose with an ionic liquid capable of solvating or dissolving at least some of the cellulose, said ionic liquid being a compound comprised solely of cations and anions and which exists in a liquid state at a temperature at or below 150 Deg. C, the cations in said ionic liquid having the general formula (I); and treating the resulting solvate or solution with an acid in the presence of water, said acid having a pKa in water of less than 2 at 25 Deg. C, wherein said acid may be selected from hydrogen halides, sulfuric acid, nitric acid, halo carboxylic acids, halo sulfonic acids, tetrafluoroboric acid, heteropolyacids, aryl- and alkyl-sulfonic acids, and halogenated alkyl- and arylsulfonic acids, preferably the acid may be selected from p-toluenesulfonic acid, trifluoromethanesulfonic acid, trichloromethanesulfonic acid, trifluoroacctic acid, hydrochloric acid, hydrobromic acid, hydriodic acid, tetrafluoroboric acid, sulfuric acid, nitric acid, methanesulfonic acid, or hydrochloric acid.
Patent NZ-588756-A (NZ)
Title: Method for producing metal-based materials for magnetic cooling or heat pumps
Inventor: BRUCK EKKEHARD
IPC: H01F1/01
Filed: 2009-04-27
Abstract: Disclosed is a process for preparing metal-based materials for magnetic cooling or heat pumps, comprising the following steps: a) reacting metallic elements and/or alloys in a stoichiometry which corresponds to the metal-based material in the solid phase and/or liquid phase to form a metal-based material, b) if appropriate converting the reaction product from stage a) to a solid, c) sintering and/or heat treating the solid from stage a) or b), d) quenching the sintered and/or heat treated solid from stage c) at a cooling rate in the range from 200 to 1300 Kelvin per s.
Patent NZ-589184-A (NZ)
Title: Automated point of sale expanded colour space paint and stain tinting dispenser system with high strength red, green and blue colorants
Inventor: KORENKIEWICZ STEPHEN M
IPC: C09D7/80
Filed: 2009-06-16
Abstract: A retail point of sale expanded color space white-pigmented paint and non-pigmented stain custom tinting dispenser system with an automated colorant or pigment dye dispenser having a minimum liquid dispensing quantity less than 0.01 fluid ounce or 0.3 cm3 typically less than 0.005 fluid ounce or 0.15 cm3. No more than twelve colorants are used, typically ten or less. The colorants used include white; black; yellow hued; green-hued colorant having a colour strength greater than 12 wt. % PG7 pigment and typically 20-48% PG7 pigment; blue-hued colorant containing at least 7 wt. % PB 15:2 pigment and typically 12-28% PB15:2 pigment; and red-hued colorant at least containing 17 wt. % PR209 pigment and typically 29-68% PR209 pigment.
Patent NZ-589351-A (NZ)
Title: A retractable screen with a break system so the screen may be held at any point along its extent
Inventor: ROBERTS ANTHONY GERARD
IPC: E06B9/56
Filed: 2010-11-18
Abstract: A retractable screen (10) for extending across an architectural opening is disclosed. The retractable screen includes a fixed side having a fixed screen post (12). A displaceable handle post with an upper region and a lower region can move away from the fixed side towards a closed position, and move towards the fixed side back into an open position. At least one of an upper guide track and a lower guide track (18) engages with the upper or lower region of the handle post and guides the movement of the handle post between the open and closed positions. The retractable screen further includes a flexible sheet mesh (24) extending between the fixed side and the displaceable handle post. Since the screen is biased to rewind into the fixed screen post, a brake arrangement is supplied so that the movable handle post can be stopped and retained in any desired position between the open and the closed positions. The brake includes at least one brake assembly that is displaced into engagement with said at least one of the upper or lower (18) guide tracks to apply a braking action to the handle post.
Patent NZ-590186-A (NZ)
Title: A portable roof anchor screwed to roof though ridges having an energy absorber connected to a harness
Inventor: PRIDHAM ANDREW DOUGLAS
IPC: E04G21/32
Filed: 2009-07-01
Abstract: A safety anchor (10) to be attached to a roof (11) to arrest a fall is disclosed. The anchor includes an elongated body (17) having a pair of slots (19, 20) through which threaded fasteners (22) pass to secure the anchor to the ridges (13) of the roof. The slots enable the anchor to be securely attached to the roof regardless of the ridge spacing. Secured to the body is a harness attachment (25) that is in the form of a metal strip that is bent about several transverse axes so as to have a plurality of bends (27). When a force beyond a predetermined level is applied to the member it plastically deforms to absorb energy and arrest the fall in a controlled manner.
Patent NZ-594187-A (NZ)
Title: Waste Treatment Process
Inventor: IRVINE DAVID LEIGH
IPC: A62D3/00
Filed: 2011-07-21
Abstract: Disclosed herein is a method of treating spent pot liner (SPL) material or materials having similar compositions thereto, the method including the steps of: Placing a SPL mixture into a kiln (preferably a counter current fired rotary kiln), wherein the mixture includes SPL material, a silicon source (preferably selected from one or more of silicon dioxide, waste glass, silicon sand), a calcium source (preferably selected from one or more of calcium carbonate, calcium oxide, calcium hydroxide) and an iron source, and Heating the SPL mixture to a tempereature in the range of 1050°C to 1150°C to cause combustion of the carbon in the SPL material and melting of the SPL mixture to form a slag, and Discharging the resulted slag from the kiln, The method being characterised by: Ensuring the percentage of iron within the net SPL mixture is in the range of 5-20%w/w.
Patent NZ-596036-A (NZ)
Title: Toll-like receptor 3 antagonists
Inventor: LUO JINQUAN
IPC: C12P21/06
Filed: 2010-04-29
Abstract: 596036 Disclosed is an isolated antibody or fragment thereof, wherein the antibody binds toll-like receptor 3 (TLR3) amino acid residues K416, K418, L440, N441, E442, Y465, N466, K467, Y468, R488, R489, A491, K493, N515, N516, N517, H539, N541, S571, L595, and K619 of sequence MRQTLPCIYFWGGLLPFGMLCASSTTKCTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSSCKDSAPFELFFMINTSILLIFIFIVLLIHFEGWRISFYWNVSVHRVLGFKEIDRQTEQFEYAAYIIHAYKDKDWVWEHFSSMEKEDQSLKFCLEERDFEAGVFELEAIVNSIKRSRKIIFVITHHLLKDPLCKRFKVHHAVQQAIEQNLDSIILVFLEEIPDYKLNHALCLRRGMFKSHCILNWPVQKERIGAFRHKLQVALGSKNSVH.
Patent NZ-596630-A (NZ)
Title: Polymer plastic downhole centraliser with polymer plastic end rings
Inventor: PEZET PETER BRENDON THOMAS
IPC: E21B17/10
Filed: 2011-11-24
Abstract: A downhole centraliser intended to receive a downhole tubular, includes a tubular body formed 10 of a plastics material with opposed ends, and end rings 18 mounted to the ends of the tubular body. The end rings 18 are also formed from a plastics material, though the Young's modulus of the plastic material of the end rings is not greater than the Young's modulus of the plastics material of the tubular body of the centraliser. Preferably the tubular body and the end rings are formed of the same plastics material and the end rings are snap fitted onto the ends of the tubular body.
Patent NZ-603379-A (NZ)
Title: Ect2 peptides and vaccines including the same
Inventor: YOSHIMURA SACHIKO
IPC: C12N15/09
Filed: 2011-03-30
Abstract: Disclosed is a isolated peptide of less than 15 amino acids having binding affinity with HLA-A02 antigen and having cytotoxic T lymphocytes (CTL) inducibility, wherein the peptide is selected from the group consisting of: (a) an isolated peptide which comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 1, 3 and 21, and (b) an isolated peptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NOs: 1, 3 and 21 in which 1 or 2 amino acid(s) are substituted, deleted, inserted or added. >1 LLIGSTSYV >3 FLFNDCLEI >21 NLLIGSTSYV
Patent NZ-610116-A (NZ)
Title: A centrifugal separator having an inlet with wear resistance members, and a feed zone element with wear resistance members
Inventor: REIFF HENRIK
IPC: B04B1/20
Filed: 2011-12-29
Abstract: A centrifugal separator with an inlet chamber (42) inside a conveyor body comprising a proximal cross wall (36) and a distal cross wall (38). Longitudinal walls (40) extend between the proximal cross wall (36) and the distal cross wall (38). The proximal cross wall comprises a central opening (41), and feed ports (44) are present between adjacent longitudinal walls. The cross walls and longitudinal walls have internal surfaces (36a, 38a, 40a). A feed path extends from the central opening, through the inlet chamber and out through the feed ports. Wear resistance members (46a, 46b, 46c, 54, 68) insertable through the feed ports fully screen the internal surfaces of the distal cross wall and the longitudinal walls from the feed path and comprise longitudinal wall members with at least one flange portion (52).
Patent NZ-628290-A (NZ)
Title: Distinguishing closed and open respiratory airway apneas by complex admittance values
Inventor: OATES JOHN DAVID
IPC: A61M16/06
Filed: 2007-08-30
Abstract: Disclosed is an apparatus for providing a supply of continuous positive airway pressure (CPAP) to the airway of a patient. The apparatus comprises a flow generator (34), means for determining respiratory air flow (50) and pressure (48) in a patient interface (30), means for measuring patient impedance of the airway and a controller (62). The flow generator is adapted to supply CPAP therapy and is coupled to an air delivery tube (32) coupled with the patient interface. The patient interface is configured to sealingly engage with the face of the patient. The means for measuring patient impedance of the airway is used during a period of a breathing cycle when an apnea is not occurring. The controller is configured to detect the occurrence of an apnea and to determine the patency of the patient’s airway during the apnea. The controller controls application of an oscillatory pressure waveform of known frequency to the patient interface and measures an apnea impedance of the airway during the apnea. The apnea impedance is then compared with the patient impedance to determine whether the airway is patent, or obstructed (open or closed apnea).
Patent NZ-630210-A (NZ)
Title: Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids
Inventor: LAI CHRON-SI
IPC: A23L33/15
Filed: 2013-03-07
Abstract: Disclosed is a nutritional composition, preferably an infant formula, comprising at least 7 mg/L of RRR-alpha tocopherol (Vitamin E), at least 60 mg/L of docosahexaenoic acid (DHA), at least 110 mg/L of arachidonic acid (ARA), and preferably comprising at least 130 mg/L of vitamin C. Also disclosed is the use of the nutritional formula to improve brain development and cognitive performance in an individual, specifically in an infant.
Patent NZ-712539-A (NZ)
Title: Inverter device
Inventor: IWAMATSU YUSUKE
IPC: H02M7/5395
Filed: 2014-03-28
Abstract: An inverter device (1) comprises: an inverter circuit (2) connected to a DC power source (10) for converting DC power to AC power by performing PWM controls to two pairs of switching elements (Q1 - Q4) so as to be switched on and off in each predetermined cycle; a clamping circuit (3) configured of at least one switching element (Q5 – Q6) connected between two output terminals of the inverter circuit and can take one of a short-circuit state, a rectification state to be reverse bias when an output voltage from the inverter circuit is positive, a rectification state to be reverse bias when the output voltage is negative, and a cut-off state; and a control unit (5) for controlling switching on and off of the switching elements of the inverter circuit and the clamping circuit and short-circuits the clamping circuit when it switches off all of the two pairs of the switching elements; and wherein dead times are provided in an interval from switching off one pair of the switching elements or the other of the switching elements among the two pairs of the switching elements to short-circuiting the clamping circuit, and in an interval from non short-circuiting the clamping circuit to switching on the one pair of the switching elements or the other pair of the switching elements; and the control unit (5) controls the clamping circuit to take the rectification state such that the clamping circuit is in reverse bias to the output voltage during the dead times.
Patent NZ-727679-A (NZ)
Title: Manufacture of degarelix
Inventor: FOMSGAARD JENS
IPC: A61K47/12
Filed: 2013-05-31
Abstract: The present invention provides methods for producing a lyophilized degarelix product which, upon reconstitution with water for injection in an amount of 20 mg/ml, shows a viscosity of up to 15 mPas. The present invention also provides a lyophilized degarelix drug substance which shows, upon dissolution in water in an amount of 20 mg/ml, a viscosity of up to 3.2 mPas, and processes for providing this lyophilized degarelix drug substance.